Evidence map›Paper›PMID 32974334›Full record

ArticleFrontiers in cell and developmental biology2020

eIF3a Regulation of NHEJ Repair Protein Synthesis and Cellular Response to Ionizing Radiation.

Rima Tumia, Chao J Wang, Tianhan Dong, Shijie Ma, Jenny Beebe, Juan Chen, Zizheng Dong, Jing-Yuan Liu, Jian-Ting Zhang

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Proteomic profiling of eIF3a conditional knockout mice.Frontiers in molecular biosciences · 2023
    Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Rima TumiaDepartment of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN, United States.
Chao J WangDepartment of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN, United States.
Tianhan DongDepartment of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN, United States.
Shijie MaDepartment of Cancer Biology, University of Toledo College of Medicine and Life Sciences, Toledo, OH, United States.
Jenny BeebeDepartment of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN, United States.
Juan ChenDepartment of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN, United States.
Zizheng DongDepartment of Cancer Biology, University of Toledo College of Medicine and Life Sciences, Toledo, OH, United States.
Jing-Yuan LiuDepartment of Medicine, University of Toledo College of Medicine and Life Sciences, Toledo, OH, United States.
Jian-Ting ZhangDepartment of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN, United States.
Indiana University – Purdue University Indianapolis · USUniversity of Toledo · USIndiana University School of Medicine

Funding

Molecular targeting the translational control axis in Wnt/β-catenin signaling pathwayR01CA211904 · NCI · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI ZHANG, JIAN-TING · 2017 to 2022
$1.8M
NCI NIH HHS R01 CA211904
6 · The paper itself

Abstract

Translation initiation in protein synthesis regulated by eukaryotic initiation factors (eIFs) is a crucial step in controlling gene expression. eIF3a has been shown to regulate protein synthesis and cellular response to treatments by anticancer agents including cisplatin by regulating nucleotide excision repair. In this study, we tested the hypothesis that eIF3a regulates the synthesis of proteins important for the repair of double-strand DNA breaks induced by ionizing radiation (IR). We found that eIF3a upregulation sensitized cellular response to IR while its downregulation caused resistance to IR. eIF3a increases IR-induced DNA damages and decreases non-homologous end joining (NHEJ) activity by suppressing the synthesis of NHEJ repair proteins. Furthermore, analysis of existing patient database shows that eIF3a expression associates with better overall survival of breast, gastric, lung, and ovarian cancer patients. These findings together suggest that eIF3a plays an important role in cellular response to DNA-damaging treatments by regulating the synthesis of DNA repair proteins and, thus, eIIF3a likely contributes to the outcome of cancer patients treated with DNA-damaging strategies including IR.

Indexed as

DNA repaireukaryotic initiation factor 3a (eIF3a)gamma-H2A histone family member X (γ-H2AX)mRNA translationprotein synthesisradiationresistance

Identifiers

PMID32974334
PMCPMC7466773
OpenAlexW3051105556

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.